Low Dose Naltrexone (LDN)
Naltrexone is a drug that blocks the effects of drugs called opioids. Naltrexone has been used as a treatment for addiction to opioids as well as alcohol, and traditionally prescribed between 50-300 mg. Naltrexone is FDA approved and Health Canada approved. Since the mid- to late-1980’s it has been used in low doses of 0.5-4+ mg per day, as an immunomodulator in people with HIV/AIDS, cancer, autoimmune and neurodegenerative diseases. Some of the conditions include Hashimoto’s thyroiditis, multiple sclerosis (MS), psoriasis, Crohn’s, ulcerative colitis, rheumatoid arthritis (RA), as well as central nervous system disorders. LDN works by upregulating the levels of natural opioid activity in the body called OGF. Use of LDN in many health conditions is considered “off-label”. The safety profile of low dose naltrexone is excellent when prescribed by an experienced physician.
Linda Elsgood of LDN Research Trust. Linda is an editor of an excellent book, The LDN Book, make sure to get your copy.
To learn more about LDN, please listen to the following interview from February 2018.
Here is Dr. Igor Schwartzman with Linda Elsgood.
